Celcuity Inc is a biotechnology company focused on transforming the treatment of cancer by advancing its proprietary Celcuity Platform, which is designed to identify specific cellular behaviors that drive the disease. The company aims to develop innovative targeted therapies by leveraging insights from patient-derived tumor samples. By utilizing its unique approach, Celcuity seeks to enhance the precision of cancer treatment, ultimately improving patient outcomes through personalized medicine. Read More
Peraso Inc. (NASDAQ: PRSO), a leader in 60GHz mmWave wireless technology, is rapidly expanding its global footprint through dual momentum in defense and broadband sectors. In a key commercial milestone, Tachyon Networks has selected Peraso’s PRM2141X module for its new TNA-303L-65 —a compact outdoor wireless solution delivering fiber-class speeds up to 1 Gbps across 3+ km, without the need for costly trenching.
Sara Hurvitz, co-principal investigator for the trial, said that the data for both combination treatments in the trials are “potentially practice-changing.”
